638 related articles for article (PubMed ID: 24184425)
1. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
2. Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: role of surfactant protein B and C.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Acta Biomater; 2014 Nov; 10(11):4678-4684. PubMed ID: 25087869
[TBL] [Abstract][Full Text] [Related]
3. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
Palmblad M; Johansson J; Robertson B; Curstedt T
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
[TBL] [Abstract][Full Text] [Related]
4. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
Seeger W; Thede C; Günther A; Grube C
Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
[TBL] [Abstract][Full Text] [Related]
5. SP-B refining of pulmonary surfactant phospholipid films.
Nag K; Munro JG; Inchley K; Schürch S; Petersen NO; Possmayer F
Am J Physiol; 1999 Dec; 277(6):L1179-89. PubMed ID: 10600889
[TBL] [Abstract][Full Text] [Related]
6. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro.
Beck-Broichsitter M; Ruppert C; Schmehl T; Guenther A; Betz T; Bakowsky U; Seeger W; Kissel T; Gessler T
Nanomedicine; 2011 Jun; 7(3):341-50. PubMed ID: 21059405
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein interactions with neutral and acidic phospholipid films.
Rodriguez-Capote K; Nag K; Schürch S; Possmayer F
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L231-42. PubMed ID: 11404266
[TBL] [Abstract][Full Text] [Related]
8. Biophysical Activity of Impaired Lung Surfactant upon Exposure to Polymer Nanoparticles.
Beck-Broichsitter M
Langmuir; 2016 Oct; 32(40):10422-10429. PubMed ID: 27641633
[TBL] [Abstract][Full Text] [Related]
9. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
Seeger W; Grube C; Günther A; Schmidt R
Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
[TBL] [Abstract][Full Text] [Related]
10. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures.
Yu SH; Possmayer F
Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863
[TBL] [Abstract][Full Text] [Related]
11. Surface activity and film formation from the surface associated material of artificial surfactant preparations.
Palmblad M; Gustafsson M; Curstedt T; Johansson J; Schürch S
Biochim Biophys Acta; 2001 Feb; 1510(1-2):106-17. PubMed ID: 11342151
[TBL] [Abstract][Full Text] [Related]
12. Effect of pulmonary surfactant protein B (SP-B) and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine.
Yu SH; Possmayer F
Biochim Biophys Acta; 1992 Jun; 1126(1):26-34. PubMed ID: 1606172
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.
Yu SH; Possmayer F
Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500
[TBL] [Abstract][Full Text] [Related]
14. Compatibility of PEGylated Polymer Nanoparticles with the Biophysical Function of Lung Surfactant.
Beck-Broichsitter M
Langmuir; 2018 Jan; 34(1):540-545. PubMed ID: 29220196
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.
Seeger W; Günther A; Thede C
Am J Physiol; 1992 Mar; 262(3 Pt 1):L286-91. PubMed ID: 1550251
[TBL] [Abstract][Full Text] [Related]
16. Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro.
Bakshi MS; Zhao L; Smith R; Possmayer F; Petersen NO
Biophys J; 2008 Feb; 94(3):855-68. PubMed ID: 17890383
[TBL] [Abstract][Full Text] [Related]
17. Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted pulmonary surfactants.
Yu SH; Possmayer F
Biochim Biophys Acta; 1993 Apr; 1167(3):264-71. PubMed ID: 8481387
[TBL] [Abstract][Full Text] [Related]
18. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
[TBL] [Abstract][Full Text] [Related]
19. Tuning the size of styrene-maleic acid copolymer-lipid nanoparticles (SMALPs) using RAFT polymerization for biophysical studies.
Craig AF; Clark EE; Sahu ID; Zhang R; Frantz ND; Al-Abdul-Wahid MS; Dabney-Smith C; Konkolewicz D; Lorigan GA
Biochim Biophys Acta; 2016 Nov; 1858(11):2931-2939. PubMed ID: 27539205
[TBL] [Abstract][Full Text] [Related]
20. Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin.
Kolomaznik M; Calkovska A; Herting E; Stichtenoth G
Adv Exp Med Biol; 2015; 839():31-9. PubMed ID: 25252905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
